Drug
Ihl 42x Dronabinol Acetazolamide
Ihl 42x Dronabinol Acetazolamide: highest development phase Phase 2, developed by Incannex Healthcare Ltd. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Incannex Healthcare Ltd
Trials
| Drug | Phase | Indication |
|---|---|---|
| IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamide NCT07635563 | Phase 2 | Obstructive Sleep Apnea (OSA) |
Latest
No recent events.
Follow Ihl 42x Dronabinol Acetazolamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.